An underwear run in Seaside Heights, and more things to do this weekend at the Shore
What will you be doing this weekend around the Jersey Shore? Cupid's Undie Run, Chili Cook-Off, Black History Month ...
Folio Weekly22h
They Take Their Pants Off for Charity: Cupid’s Undie Run
Words by Ambar Ramirez Often called the month of love, February brings plenty of ways to celebrate — Galentine’s parties, pajama and pizza nights, and, of course, Super Bowl gatherings. But perhaps th ...
Cupid's Undie Run returns to DC this Saturday, raising funds for NF research
Runners are encouraged to strip down to their underwear or don creative costumes to raise awareness and money for NF with ...
Cupid’s Undie Run returns to Reno to raise awareness for neurofibromatosis
RENO, Nev. (KOLO) - Saturday, Feb. 22 hundreds of people in Reno will take to the streets in just their undies during Cupid’s Undie Run. The event raises awareness of neurofibromatosis (NF), a genetic ...
BioWorld1d
Springworks’ Gomekli wins priority FDA nod for NF1 neurofibromas
Snagging its second U.S. FDA approval since being spun out of Pfizer Inc. in 2017, Springworks Therapeutics Inc. is aiming to position Gomekli (mirdametinib), cleared for neurofibromatosis type ...
The American Journal of Managed Care1d
FDA Approves Mirdametinib for Neurofibromatosis Type 1 With Plexiform Neurofibromas
Adult and pediatric patients with neurofibromatosis type 1 who have symptomatic plexiform neurofibromas that are not amenable ...
BioSpace2d
SpringWorks Wins FDA Nod for Neurofibromatosis Drug, Tees Up Challenge to AstraZeneca
The FDA on Tuesday signed off on SpringWorks Therapeutics’ mirdametinib—now to carry the brand name Gomekli—for the treatment ...
GlobalData on MSN2d
FDA approves Gomekli as first neurofibromatosis drug for adults
The US Food and Drug Administration (FDA) has approved SpringWorks Therapeutics’ Gomekli (mirdametinib) to treat ...
fandomwire2d
What Is Neurofibromatosis? Condition Behind Adam Pearson’s Face
Adam Pearson used his neurofibromatosis struggles to succeed in acting and advocacy, inspiring others to accept differences ...
Hartford Business2d
FDA approves CT drugmaker’s therapy for rare cancer tumors
Stamford-based SpringWorks Therapeutics, a commercial-stage biotech company developing treatments for rare diseases and ...
FDA approves new genetic disorder drug
The Food and Drug Administration (FDA) approved a new drug to treat a disorder causing the growth of noncancerous tumors on ...
SpringWorks Therapeutics Announces FDA Approval of GOMEKLIâ„¢ (mirdametinib) for the Treatment of Adult and Pediatric Patients with NF1-PN
GOMEKLI is the first and only medicine approved for both adults and children with NF1-PN –– Approval based on positive data ...